The RSV vaccination eligibility age has been lowered from 60 years to 50 years according to an update on the CDC website.

Salarius also announces continued progress in its planned merger with Decoy Therapeutics Inc. (Decoy). Under the definitive agreement announced on January 13, 2025, Decoy will merge with a wholly ...

During the monsoon season, raw ginger water emerges as a natural remedy to combat respiratory issues. Its anti-inflammatory ...

What you need to knowNB.1.8.1. — also called \"Nimbus” — is a subvariant of the dominant Omicron variant of SARS-CoV-2.It has ...

The rapid identification of respiratory virus outbreaks is needed to enable rational and effective public health interventions. We developed new quantitative approaches for simultaneous ...

Adults as young as 50 may now qualify for an RSV vaccine if they have certain health conditions, according to a quiet update ...

For Nick, watching his eight-year-old daughter perform onstage to over a hundred people, including Aussie actors, felt like a ...

India has over 2,500 political parties — Prime Minister Modi shocks Ghana's Parl ...

The Bronchopulmonary Dysplasia Treatment Market is anticipated to be valued at USD 434.1 million in 2025 and is expected to reach USD 788.2 million by 2035, registering a CAGR of 6.1%. The ...

UBS reaffirmed its Buy rating and $105 target for Merck, brushing off investor pessimism about the pharmaceutical giant’s ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

Nantucket is the latest community to start testing its sewage for drugs—partnering with a Cambridge firm that analyzes sewage ...